We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Fundamental aspects
-
1. Inflammation and tissue homeostasis
- Prof. Herman Waldmann
-
2. Introduction to the immune system
- Prof. Herman Waldmann
-
3. Hematopoiesis: the making of an immune system
- Prof. Paul J. Fairchild
-
4. Inflammation: purposes, mechanisms and development
- Prof. Pietro Ghezzi
-
5. Phagocytosis
- Dr. Eileen Uribe-Querol
-
6. Regulated cell death mechanisms and their crosstalk with the immune system 1
- Dr. Luis Alberto Baena-Lopez
-
7. Regulated cell death mechanisms and their crosstalk with the immune system 2
- Dr. Luis Alberto Baena-Lopez
- Innate immunity
-
11. Cells of the innate immune system
- Prof. Kevin Maloy
-
12. Microbial recognition and the immune response
- Dr. Dana Philpott
-
13. Toll-like receptor signalling during infection and inflammation
- Prof. Luke O'Neill
- Intercellular mediators
-
14. Chemokines
- Dr. James E. Pease
-
15. Cytokines
- Prof. Iain McInnes
-
16. IL-1 family cytokines as the canonical DAMPs of the immune system
- Prof. Seamus Martin
-
17. Glycans at the frontiers of inflammation, autoimmunity and cancer
- Prof. Salomé S. Pinho
-
18. Glycoimmunology
- Prof. Paula Videira
- Adaptive immunity B cells
-
21. Antigen recognition in the immune system
- Prof. Herman Waldmann
-
22. B cell biology
- Prof. Richard Cornall
-
23. Antibody structure and function: antibody structure
- Dr. Mike Clark
-
24. Antibody structure and function: antibody function
- Dr. Mike Clark
-
25. Antibody genes and diversity
- Dr. Mike Clark
-
26. In vivo antibody discovery and hybridoma technology
- Prof. Dr. Katja Hanack
-
27. Antibody engineering: beginnings to bispecifics and beyond
- Dr. Ian Wilkinson
-
29. The immunobiology of Fc receptors
- Prof. Mark Cragg
-
30. Immunoreceptors
- Prof. Anton van der Merwe
-
31. Affinity, avidity and kinetics in immune recognition
- Prof. Anton van der Merwe
- Adaptive immunity T cells
-
32. The thymus and T cell development: a primer
- Prof. Georg Holländer
-
33. Lineage decisions in the thymus: T cell lineage commitment
- Prof. Bruno Silva-Santos
-
34. Lineage decisions in the thymus: αβ and γδ T cell lineages
- Prof. Bruno Silva-Santos
-
35. CD4 T cell subsets
- Dr. Brigitta Stockinger
-
36. Cytotoxic T lymphocytes
- Prof. Gillian M. Griffiths
-
37. Gamma delta T-cells
- Prof. Bruno Silva-Santos
-
38. Tfh and Tfr cells
- Prof. Luis Graca
-
39. Tissue resident memory T cells (TRM)
- Dr. Marc Veldhoen
-
40. Mathematical modeling in immunology
- Prof. Ruy M. Ribeiro
- The importance of the MHC in immunity
-
41. The MHC and MHC molecules 1
- Prof. Jim Kaufman
-
42. The MHC and MHC molecules 2
- Prof. Jim Kaufman
-
43. Natural killer cells
- Dr. Philippa Kennedy
-
44. Human NK cells
- Prof. Lorenzo Moretta
-
46. NK cells in viral immunity
- Prof. Lewis Lanier
- Lymphocyte activation
-
47. Signal transduction by leukocyte receptors
- Dr. Omer Dushek
-
48. Immunological memory 1
- Prof. David Gray
-
49. Immunological memory 2
- Prof. David Gray
-
50. Studying immune responses “one cell at a time”
- Dr. Mir-Farzin Mashreghi
- Major cellular partners in immunity
-
51. The mononuclear phagocyte system - tissue resident macrophages: distribution and functions
- Prof. Emeritus Siamon Gordon
-
52. The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
- Prof. Emeritus Siamon Gordon
-
53. Dendritic cells: professional antigen presenting cells
- Prof. Paul J. Fairchild
-
54. Mucosal immunology
- Prof. Daniel Mucida
- Immunological tolerance and regulation
-
55. Self-tolerance
- Prof. Herman Waldmann
-
56. Tolerance and autoimmunity
- Prof. Emerita Anne Cooke
-
57. The balance between intestinal immune homeostasis and inflammation
- Prof. Dr. Janneke Samsom
- Translational immunology - immune deficiency
-
58. Primary immunodeficiency disorders
- Dr. Smita Y. Patel
-
59. Changes in innate and adaptive immunity during human ageing 1
- Dr. Roel De Maeyer
-
60. Changes in innate and adaptive immunity during human ageing 2
- Dr. Roel De Maeyer
-
61. The aging immune system
- Prof. Ana Caetano
- Translational immunology - protection against pathogenic microbes
-
62. Immune responses to viruses
- Prof. Paul Klenerman
-
63. HIV and the immune system
- Prof. Quentin Sattentau
-
64. COVID-19: the anti-viral immune response
- Prof. Danny Altmann
-
65. Bacterial immune evasion
- Prof. Christoph Tang
-
66. The immunology underlying tuberculosis
- Prof. Thomas R. Hawn
-
67. Innate immunity to fungi
- Prof. Gordon D. Brown
-
68. Parasite immunity: introduction and Plasmodium
- Dr. Catarina Gadelha
-
69. Parasite immunity: Leishmania and Schistosoma
- Dr. Catarina Gadelha
-
70. Vaccination
- Dr. Anita Milicic
-
71. The history of vaccines 1
- Prof. Emeritus Anthony R. Rees
-
72. The history of vaccines 2
- Prof. Emeritus Anthony R. Rees
-
73. The history of vaccines 3
- Prof. Emeritus Anthony R. Rees
-
74. The science of vaccine adjuvants
- Dr. Derek O'Hagan
- Translational immunology - hypersensitivity, autoimmune disease and their management
-
75. Hypersensitivity diseases: type 1 hypersensitivity
- Prof. Herman Waldmann
-
76. Innate lymphoid cells in allergy
- Prof. Emeritus Shigeo Koyasu
-
77. Hypersensitivity diseases: type II-IV hypersensitivity
- Prof. Sara Marshall
-
78. Immune memory underlying lifelong peanut allergy
- Dr. Kelly Bruton
-
79. Memory B cells in allergy: B cell activation and response
- Dr. Kelly Bruton
-
80. Memory B cells in allergy: ontogeny, phenotype and plasticity
- Dr. Kelly Bruton
-
81. B cells at the crossroads of autoimmune diseases
- Dr. Xiang Lin
-
82. Interleukin-17: from clone to clinic
- Prof. Leonie Taams
-
83. Autoimmunity and type 1 diabetes
- Prof. Emerita Anne Cooke
-
84. What is new in type 1 diabetes?
- Prof. Åke Lernmark
-
85. Antibodies to control or prevent type 1 diabetes
- Dr. Robert Hilbrands
-
86. Monoclonal antibodies in haemato-oncology
- Prof. Mark Cragg
-
87. Therapeutic antibodies
- Dr. Geoffrey Hale
-
88. Endothelial cells: regulators of autoimmune-neuroinflammation
- Dr. Laure Garnier
-
89. Neuroimmunometabolism
- Prof. Ana Domingos
-
90. The immunology of multiple sclerosis
- Dr. Joanne Jones
-
91. Immunology of the peripheral nervous system: the inflammatory neuropathies
- Dr. Simon Rinaldi
-
92. Ocular immunology: an overview of immune mechanisms operating in the eye
- Dr. Eleftherios Agorogiannis
-
93. Understanding myasthenia gravis and advances in its management
- Prof. Henry J. Kaminski
-
94. The immunology underlying rheumatic diseases
- Dr. Hussein Al-Mossawi
-
96. Complement and lupus
- Prof. Marina Botto
-
97. Immune mechanisms in liver diseases
- Prof. Paul Klenerman
- Translational immunology - transplantation immunology
-
98. Principles of transplantation: overview of the immune response
- Prof. Emerita Kathryn Wood
-
99. Factors influencing outcomes in clinical transplantation 1
- Prof. Emerita Kathryn Wood
-
100. Factors influencing outcomes in clinical transplantation 2
- Prof. Emerita Kathryn Wood
- Translational immunology - cancer immunology
-
101. Cancer immunology
- Prof. Tim Elliott
-
102. Cancer immunotherapy
- Prof. Tim Elliott
-
103. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
104. IL-2 in the immunotherapy of autoimmunity and cancer
- Prof. Thomas Malek
-
105. Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
- Dr. Else Marit Inderberg
Printable Handouts
Navigable Slide Index
- Introduction
- What is multiple sclerosis?
- Multiple sclerosis scans
- Multiple sclerosis form of the disease
- What causes MS?
- Environmental exposure and genetic susceptibility
- The environmental factors - viruses
- The environmental factors
- The genetics of MS
- The genetics of MS - alleles of the MHC
- A complex, multicellular process that evolves throughout the course of the disease
- Autoreactive T-cells
- Autoreactive T-cells: evidence from EAE
- Autoreactive B cells
- Defective immune regulation (1)
- Tregs suppress via several mechanisms
- Defective immune regulation (2)
- The role of myeloid cells in MS
- The MS immune cascade
- How is MS treated?
- Disease modifying treatment (DMTs)
- Treatment efficacy
- Summary
Topics Covered
- Multiple sclerosis (MS)
- Form of the disease
- Environmental exposure and genetic susceptibility
- Defective immune regulation
- How is MS treated?
- Disease modifying treatment (DMTs)
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Jones, J. (2020, July 30). The immunology of multiple sclerosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/POPV9845.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Joanne Jones has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Neurology
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Joanne Jones.
I'm a Consultant Immunologist at Addenbrooke's Hospital in Cambridge.
I also run an immunology research group at the University.
The aim of my talk is to give you an overview on the immunology of multiple sclerosis.
0:17
What is multiple sclerosis?
Well, multiple sclerosis can be best defined as
an auto-immune demyelinating disease of the central nervous system.
Autoimmune refers to the fact that it's caused by
the patient's own immune system mistakenly attacking cell.
In particular, what the immune system attacks in
multiple sclerosis is myelin, which is a fatty substance that
surrounds the axons of nerves protecting them
and enabling them to conduct electrical impulses efficiently.
When we talk to patients about multiple sclerosis,
what it is and what myelin is,
it's often helpful to ask them to think of it as being similar to
the protective plastic outer coating of
electrical wires where the wire is equivalent to the axon.
In multiple sclerosis, protective coating is
damaged and the myelin is stripped from the nerve.
In other words the nerves become demyelinated.
Myelin is produced by oligodendrocytes which is specialized cells
within the central nervous system and by that I mean the brain and the spinal cord.
MS affects approximately 2.5 million people worldwide.
It's a major cause of disability in young adults particularly women,
as women are affected three times more commonly than men.
It also has significant personal and socioeconomic costs
as the average age of onset is 30 years.
Approximately 25 years after diagnosis,
50 percent of individuals require permanent use of a wheelchair.
It's a very serious and life altering condition.